You are here: Home » Current Affairs » News
Business Standard

India supplies non-J&J vaccines to Cambodia, Thailand under Quad umbrella

The Quad was originally supposed to supply J&J doses made by Indian company Biological E Ltd to Southeast Asian and other countries, as a counter to China's vaccine donations around the world

Topics
Coronavirus Vaccine | Quad | External Affairs Ministry

Reuters  |  New Delhi 

Coronavirus vaccine, Covid-19 vaccines
Representative image

India has supplied COVID-19 vaccines to and under an initiative of the group of countries, New Delhi said on Thursday, though not the Johnson & Johnson shot as originally planned.

The leaders of the countries - India, the United States, Japan and Australia - could discuss the vaccine supply plan when they meet in Japan on Tuesday, Indian foreign ministry spokesperson Arindam Bagchi told a news conference.

"We have sent, under the umbrella, vaccines to and Thailand," Bagchi said.

"Yes, the original plan was to use a different modality, but the final objective is to ensure that vaccines are shared under the Quad umbrella to those countries who need them."

Bagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax vaccine made by the Serum Institute of India (SII), to under the Quad programme.

India separately shipped 325,000 doses of Covishield, a version of the AstraZeneca shot made by the SII, to Cambodia, the data shows.

The Quad was originally supposed to supply J&J doses made by Indian company Biological E Ltd to Southeast Asian and other countries, as a counter to China's vaccine donations around the world.

Biological E did not immediately respond to a request for comment. Reuters could not immediately contact J&J.

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, May 20 2022. 12:39 IST
RECOMMENDED FOR YOU